There are over forty members of the class of compounds known as plant steroidal hormones.
There are over forty members of the class of compounds known as plant steroidal hormones. [1] [2] They are collectively named brassinosteroids (BRs). Among these, castasterone (CS) and brassinolide (BL) are considered the most important BRs because of their strong biological activities and wide-distribution in the plant kingdom. CS is biosynthesized from 24-methylcholesterol via two parallel pathways, namely, the early and late C-6 oxidation pathways, and then CS is further oxidized by 7-oxalactonation to produce BL. In the late C-6 oxidation pathway (Fig. 1) , conversion of 6-deoxoCS to CS is catalyzed by two BR 6-oxidases which are cytochrome P450s designated as CYP85A1 and A2. 3 Recently we found that CYP85A2, has additional effects on BL synthase-it mediates the conversion of CS to BL, indicating that CYP85A2 is a bi-functional enzyme for BL synthase as well as for BR 6-oxidase. 4 As shown in Fig. 1 , accumulating evidence suggests that plants operate multiple biosynthetic pathways to synthesize diverse naturally-occurring BRs such as 28-norBRs (C27-BRs), 24-methylene-BRs (C 28 -BRs), 24-methyl-BRs (C 28 -BRs) and 24-ethyl-BRs (C 29 -BRs). 5 Although carbon skeletons, especially the alkyl groups at C-24, are different in C27-, C28-and C29-BR biosynthesis, biosynthetic reactions involved in the multiple BR biosyntheses are thought to be basically identical, suggesting that the same genes or proteins characterized in 24-methyl-BR biosynthesis are likely to catalyze the corresponding biosynthetic reactions for the other BR biosyntheses. 3 To test the possibility, involvement of CYP85A1 and A2, which are potentially useful proteins for enhancing BRs activity to develop commercially valuable plants, in 28-nor-, 24-methylene-and 24-ethyl-BRs biosynthesis was investigated in this study.
The preparation of Cyt P450 overexpressing yeast strains (CYP85A1/V60/WAT21 and CYP85A2/V60/WAT21) and galactose induction were done as previously described. 6 Galactose-induced cells were diluted in 20 mL of YPL to an OD 550 of 0.4 to 0.6 and about 5 ug of suitable substrates were added to the cells. After 6 hrs, metabolites were extracted using 20 mL of ethyl acetate and then subjected to reversed-phase HPLC (RP-HPLC) (SenshuPak C 18 , 10 × 150 mm) with a flow rate of 2.5 mL/min and 45% acetonitrile as the elution. Fractions were collected every minute. Fractions corresponding to the retention times of authentic BRs for expected products (28-norBL, DL: 10 min; 28-norCS, DS, BL: 14 min; 28-HBL: 16 min; CS: 20 min) were collected and analyzed by GC-MS after suitable derivatizations. 4 First, successful expressions of CYP85A1 and A2 in yeast strains (CYP85A1/V60/WAT21 and CYP85A2/V60/WAT21) were examined. When 6-deoxo-CS was added as a substrate, as summarized Table 1 , the expressed CYP85A1 and CYP85A2 catalyzed the conversion of 6-deoxo-CS to CS. When CS was used as a substrate, the expressed CYP85A2 induced production of BL, but CYP85A1 did not. Therefore, it is confirmed that the function of the expressed CYP85A1 and A2 is correct.
Second, a possible function of CYP85A1 and CYP85A2 in 28-nor-, 24-methylene-and 28-ethyl-BRs biosynthesis was examined. When 6-deoxo-28-norCS was added as a substrate, both CYP85A1 and CYP85A2 produced 28-norCS by 6-oxidation of 6-deoxo-28-norCS. The conversion yield by CYP85A2 was higher than that by CYP85A1 (Fig. 2b) , suggesting that CYP85A2 is a more powerful BR 6-oxidase in 28-norBR biosynthesis. When 28-norCS was used as a substrate for CYP85A2, the expected product, 28-norBL, was not detected even in GC-SIM analysis, indicating that CYP85A2 is not functional in the 7-oxalactionation of 28-norCS to 28-norBL in 24-methylene-BR biosynthesis. When 6-deoxoDS was added as a substrate for both CYP85A1 and CYP85A2, CYP85A2 catalyzed conversion of 6-deoxoDS to DS, but CYP85A1 did not (Table 1 and Fig. 2c) , showing that only CYP85A2 has BR 6-oxidase activity in 24-methylene-BR biosynthesis. When DS was used as a substrate for CYP85A2, no DL was identified as a product of CYP85A2, indicating that CYP85A2 has only BR 6-oxidase activity in 24-methylene-BR biosynthesis. When 28-homoCS was added as a substrate for CYP85A2, CYP85A2 did not generate 28-homoBL, implying that CYP85A2 has no 28-homoBL synthase activity in 24-ethyl-BR biosynthesis.
In the rice lamina inclination test, 6-deoxo-BRs such as 6-deoxo-28-norCS, 6-deoxoDS and 6-deoxoCS showed no biological activity.
3-7 6-Keto-BRs, 28-norCS, DS, CS and 28-homoCS, exhibited quite strong activity, indicating that 6-oxidation is important for acquiring BR activity. 28-norBL, DL, BL and 28-homoBL show approximately 5 to 10 times higher activity than 28-norCS, DS, CS and 28-homoCS, respectively. These findings show that enzymes catalyzing 6-oxidation and 7-oxa-lactonation are important candidates for increasing BR activity for the development of commercially useful plants.
Both CYP85A1 and CYP85A2 consist of 465 amino acids. 3 They share 83% identity and 92% similarity. In spite of this, CYP85A1 and CYP85A2 possess different substrate specificities for BRs. CYP85A1 can catalyze 6-oxidation of 6-deoxo-28-norCS (C24-nor) and 6-deoxoCS (C24-methyl) but not 6-deoxoDS (C24-methylene), indicating that CYP85A1 recognizes alkyl groups at the C-24 position of BRs as its substrates. In contrast, CYP85A2 can mediate 6-oxidation of 6-deoxo-28norCS (C24-nor), 6-deoxoDS (C24-methylene) and 6-deoxoCS (C24-methyl). Further, the conversion rate of 6-oxidation by CYP85A2 is much higher than that by CYP85A1 (Fig. 2) . These findings suggest that CYP85A2 is a universal and more powerful enzyme for driving BR 6-oxidation than CYP85A1 in BR biosyntheses.
As a 7-oxalactonase, CYP85A2 can catalyze 7-oxalactonation of CS (C24-methyl), yielding BL, but can not drive 7-oxalactonation of 28-norCS (C24-nor), DS (C24-methylene) and 28-homoCS (C24-ethyl) to 28-norBL, DL and 28-homoBL, respectively, which implies that CYP85A2 recognizes alkyl groups on BR side chains, especially at C-24. Therefore, CYP85A2 is not a universal BR 7-oxalactonase; it is only a BL synthase that mediates conversion of CS to BL, the last biosynthetic reaction in 24-methyl-BRs biosynthesis.
